Therapeutics for Rare and Neglected Diseases program
E93886
The Therapeutics for Rare and Neglected Diseases program is a U.S. government initiative that accelerates the discovery and development of new treatments for rare and underserved diseases that lack adequate commercial investment.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Therapeutics for Rare and Neglected Diseases program canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T789411 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
Target entity: Therapeutics for Rare and Neglected Diseases program Context triple: [National Center for Advancing Translational Sciences, operates, Therapeutics for Rare and Neglected Diseases program]
-
A.
Action and Investment to defeat Malaria (AIM)
Action and Investment to defeat Malaria (AIM) is a comprehensive global strategy and investment framework designed to guide and coordinate efforts to eliminate and ultimately eradicate malaria worldwide.
-
B.
Roll Back Malaria
Roll Back Malaria is a global partnership initiative aimed at coordinating international efforts to control and eventually eliminate malaria, particularly in the most affected regions.
-
C.
River Blindness Program
The River Blindness Program is a Carter Center initiative dedicated to eliminating river blindness (onchocerciasis) through mass drug administration, health education, and community-based disease control in affected regions.
-
D.
Guinea Worm Eradication Program
The Guinea Worm Eradication Program is a global public health initiative led by The Carter Center that aims to eliminate dracunculiasis (Guinea worm disease) through surveillance, community education, and preventive measures rather than vaccination or drug treatment.
-
E.
Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing organization that mobilizes and invests resources to accelerate the end of these three major infectious diseases worldwide.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Target entity: Therapeutics for Rare and Neglected Diseases program Target entity description: The Therapeutics for Rare and Neglected Diseases program is a U.S. government initiative that accelerates the discovery and development of new treatments for rare and underserved diseases that lack adequate commercial investment.
-
A.
Action and Investment to defeat Malaria (AIM)
Action and Investment to defeat Malaria (AIM) is a comprehensive global strategy and investment framework designed to guide and coordinate efforts to eliminate and ultimately eradicate malaria worldwide.
-
B.
Roll Back Malaria
Roll Back Malaria is a global partnership initiative aimed at coordinating international efforts to control and eventually eliminate malaria, particularly in the most affected regions.
-
C.
River Blindness Program
The River Blindness Program is a Carter Center initiative dedicated to eliminating river blindness (onchocerciasis) through mass drug administration, health education, and community-based disease control in affected regions.
-
D.
Guinea Worm Eradication Program
The Guinea Worm Eradication Program is a global public health initiative led by The Carter Center that aims to eliminate dracunculiasis (Guinea worm disease) through surveillance, community education, and preventive measures rather than vaccination or drug treatment.
-
E.
Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS, Tuberculosis and Malaria is an international financing organization that mobilizes and invests resources to accelerate the end of these three major infectious diseases worldwide.
- F. None of above. chosen
Statements (34)
| Predicate | Object |
|---|---|
| instanceOf |
United States government program
ⓘ
drug development program ⓘ |
| aim |
accelerate development of new therapeutics
ⓘ
accelerate discovery of new therapeutics ⓘ address diseases lacking adequate commercial investment ⓘ de-risk therapeutic candidates for rare and neglected diseases ⓘ |
| collaboratesWith |
academic researchers
ⓘ
non-profit organizations ⓘ small biotechnology companies ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| field |
drug discovery
ⓘ
neglected diseases ⓘ rare diseases ⓘ translational research ⓘ |
| focusesOn |
neglected tropical diseases
ⓘ
rare diseases ⓘ underserved diseases ⓘ |
| fundingSource |
United States government
ⓘ
surface form:
United States federal government
|
| goal |
enable new treatments to reach patients with neglected diseases
ⓘ
enable new treatments to reach patients with rare diseases ⓘ |
| hasAbbreviation | TRND ⓘ |
| locatedIn | Bethesda, Maryland ⓘ |
| operatedBy |
National Center for Advancing Translational Sciences
ⓘ
National Institutes of Health ⓘ |
| parentOrganization | National Institutes of Health ⓘ |
| partOf | National Center for Advancing Translational Sciences ⓘ |
| previouslyPartOf | National Human Genome Research Institute ⓘ |
| regulatoryFocus | facilitating Investigational New Drug applications ⓘ |
| supportsStage |
early clinical development
ⓘ
preclinical development ⓘ |
| typeOfSupport |
in-kind drug development expertise
ⓘ
laboratory resources ⓘ project management for therapeutic development ⓘ |
| usesModel | public–private partnership ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Subject: Therapeutics for Rare and Neglected Diseases program Description of subject: The Therapeutics for Rare and Neglected Diseases program is a U.S. government initiative that accelerates the discovery and development of new treatments for rare and underserved diseases that lack adequate commercial investment.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.